vs
Side-by-side financial comparison of Dream Finders Homes, Inc. (DFH) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.2× Dream Finders Homes, Inc.). Dream Finders Homes, Inc. runs the higher net margin — 4.8% vs 1.4%, a 3.4% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs -22.3%). Dream Finders Homes, Inc. produced more free cash flow last quarter ($136.0M vs $5.2M). Over the past eight quarters, Dream Finders Homes, Inc.'s revenue compounded faster (21.0% CAGR vs 2.8%).
Dream Finders Homes, Inc. is a U.S. homebuilding firm that constructs and sells entry-level to luxury residential properties, including single-family homes and townhomes, across high-growth domestic markets. It also provides mortgage, title insurance and home warranty services for homebuyers.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
DFH vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.4B |
| Net Profit | $58.8M | $20.2M |
| Gross Margin | — | — |
| Operating Margin | 6.4% | 4.6% |
| Net Margin | 4.8% | 1.4% |
| Revenue YoY | -22.3% | 6.4% |
| Net Profit YoY | -54.9% | 225.7% |
| EPS (diluted) | $0.57 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $969.8M | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $989.9M | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.0B | $1.3B | ||
| Q2 24 | $1.1B | $1.3B | ||
| Q1 24 | $827.8M | $1.3B |
| Q4 25 | $58.8M | $20.2M | ||
| Q3 25 | $47.0M | $28.8M | ||
| Q2 25 | $56.6M | $40.6M | ||
| Q1 25 | $54.9M | $56.7M | ||
| Q4 24 | $130.5M | $-16.1M | ||
| Q3 24 | $70.7M | $55.6M | ||
| Q2 24 | $80.9M | $77.6M | ||
| Q1 24 | $54.5M | $96.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 19.2% | — | ||
| Q1 24 | 18.0% | — |
| Q4 25 | 6.4% | 4.6% | ||
| Q3 25 | 6.3% | 5.4% | ||
| Q2 25 | 6.4% | 6.5% | ||
| Q1 25 | 7.2% | 8.3% | ||
| Q4 24 | 10.8% | 1.6% | ||
| Q3 24 | 9.2% | 4.3% | ||
| Q2 24 | 10.0% | 5.8% | ||
| Q1 24 | 8.6% | 9.0% |
| Q4 25 | 4.8% | 1.4% | ||
| Q3 25 | 4.8% | 2.1% | ||
| Q2 25 | 4.9% | 3.0% | ||
| Q1 25 | 5.5% | 4.2% | ||
| Q4 24 | 8.4% | -1.2% | ||
| Q3 24 | 7.0% | 4.4% | ||
| Q2 24 | 7.7% | 6.1% | ||
| Q1 24 | 6.6% | 7.3% |
| Q4 25 | $0.57 | $0.17 | ||
| Q3 25 | $0.47 | $0.23 | ||
| Q2 25 | $0.56 | $0.32 | ||
| Q1 25 | $0.54 | $0.44 | ||
| Q4 24 | $1.28 | $-0.12 | ||
| Q3 24 | $0.70 | $0.43 | ||
| Q2 24 | $0.81 | $0.60 | ||
| Q1 24 | $0.55 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $234.8M | $26.5M |
| Total DebtLower is stronger | $1.6B | $1.8B |
| Stockholders' EquityBook value | $1.4B | $1.7B |
| Total Assets | $3.7B | $5.9B |
| Debt / EquityLower = less leverage | 1.13× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $234.8M | $26.5M | ||
| Q3 25 | $251.0M | $60.1M | ||
| Q2 25 | $210.3M | $52.3M | ||
| Q1 25 | $297.5M | $53.2M | ||
| Q4 24 | $274.4M | $59.7M | ||
| Q3 24 | $204.9M | $191.5M | ||
| Q2 24 | $274.8M | $111.2M | ||
| Q1 24 | $239.4M | $92.6M |
| Q4 25 | $1.6B | $1.8B | ||
| Q3 25 | $1.8B | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | $1.3B | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.8B |
| Q4 25 | $1.4B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.3B | $1.7B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $1.1B | $1.9B | ||
| Q2 24 | $1.0B | $1.4B | ||
| Q1 24 | $968.7M | $1.4B |
| Q4 25 | $3.7B | $5.9B | ||
| Q3 25 | $3.8B | $5.7B | ||
| Q2 25 | $3.7B | $5.7B | ||
| Q1 25 | $3.5B | $5.7B | ||
| Q4 24 | $3.3B | $5.6B | ||
| Q3 24 | $3.3B | $8.0B | ||
| Q2 24 | $3.0B | $7.9B | ||
| Q1 24 | $2.7B | $7.9B |
| Q4 25 | 1.13× | 1.06× | ||
| Q3 25 | 1.29× | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | 1.03× | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× | ||
| Q1 24 | — | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $143.6M | $64.3M |
| Free Cash FlowOCF − Capex | $136.0M | $5.2M |
| FCF MarginFCF / Revenue | 11.2% | 0.4% |
| Capex IntensityCapex / Revenue | 0.6% | 4.2% |
| Cash ConversionOCF / Net Profit | 2.44× | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $-126.4M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $143.6M | $64.3M | ||
| Q3 25 | $-131.0M | $175.3M | ||
| Q2 25 | $-68.5M | $110.3M | ||
| Q1 25 | $-44.7M | $-3.5M | ||
| Q4 24 | $306.5M | $125.4M | ||
| Q3 24 | $-205.0M | $181.0M | ||
| Q2 24 | $-110.6M | $278.2M | ||
| Q1 24 | $-247.5M | $-66.7M |
| Q4 25 | $136.0M | $5.2M | ||
| Q3 25 | $-135.7M | $122.2M | ||
| Q2 25 | $-78.8M | $45.6M | ||
| Q1 25 | $-47.9M | $-55.8M | ||
| Q4 24 | $302.6M | $62.0M | ||
| Q3 24 | $-222.5M | $130.3M | ||
| Q2 24 | $-112.4M | $222.6M | ||
| Q1 24 | $-249.6M | $-119.2M |
| Q4 25 | 11.2% | 0.4% | ||
| Q3 25 | -14.0% | 9.0% | ||
| Q2 25 | -6.8% | 3.4% | ||
| Q1 25 | -4.8% | -4.1% | ||
| Q4 24 | 19.4% | 4.7% | ||
| Q3 24 | -22.1% | 10.2% | ||
| Q2 24 | -10.6% | 17.4% | ||
| Q1 24 | -30.2% | -9.0% |
| Q4 25 | 0.6% | 4.2% | ||
| Q3 25 | 0.5% | 3.9% | ||
| Q2 25 | 0.9% | 4.8% | ||
| Q1 25 | 0.3% | 3.9% | ||
| Q4 24 | 0.3% | 4.8% | ||
| Q3 24 | 1.7% | 4.0% | ||
| Q2 24 | 0.2% | 4.3% | ||
| Q1 24 | 0.3% | 4.0% |
| Q4 25 | 2.44× | 3.19× | ||
| Q3 25 | -2.79× | 6.09× | ||
| Q2 25 | -1.21× | 2.72× | ||
| Q1 25 | -0.81× | -0.06× | ||
| Q4 24 | 2.35× | — | ||
| Q3 24 | -2.90× | 3.25× | ||
| Q2 24 | -1.37× | 3.59× | ||
| Q1 24 | -4.54× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DFH
| Midwest Segment | $454.2M | 37% |
| Southeast Segment | $397.5M | 33% |
| Mid Atlantic Segment | $307.3M | 25% |
| Financial Services Segment | $53.7M | 4% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
